One of the key developments within the field of DCC is the use of
proteins (or other
biological macromolecules, such as
nucleic acids) to influence the evolution and generation of components within a DCL. Protein-directed DCC provides a way to generate, identify and rank novel
protein ligands, and therefore have huge potential in the areas of
enzyme inhibition and
drug discovery.
Reversible covalent reactions The development of Protein-directed DCC has not been straightforward because the reversible reactions employed must occur in
aqueous solution at biological
pH and
temperature, and the components of the DCL must be compatible with
proteins. diselenides-disulfides exchange, disulphide formation, hemithiolacetal formation, hydrazone formation, imine formation and thiol-enone exchange.
Pre-equilibrated DCL For reversible reactions that do not occur in
aqueous buffers, the pre-equilibrated DCC approach can be used. The DCL was initially generated (or pre-equilibrated) in
organic solvent, and then
diluted into
aqueous buffer containing the
protein target for selection.
Organic based reversible reactions, including
Diels-Alder and
alkene cross metathesis reactions, have been proposed or applied to Protein-directed DCC using this method.
Reversible non-covalent reactions Reversible
non-covalent reactions, such as
metal-
ligand coordination, has also been applied in Protein-directed DCC. This strategy is useful for the investigation of the optimal ligand
stereochemistry at the
binding site of the target
protein.
Enzyme-catalysed reversible reactions Enzyme-catalysed reversible reactions, such as
protease-catalysed
amide bond formation/hydrolysis reactions and the
aldolase-catalysed
aldol reactions, have also been applied to Protein-directed DCC.
Analytical methods Protein-directed DCC system must be amenable to efficient
screening.
Multi-protein approach Although most applications of Protein-directed DCC to date involved the use of single protein in the DCL, it is possible to identify protein ligands by using multiple proteins simultaneously, as long as a suitable analytical technique is available to detect the protein species that interact with the DCL components. This approach may be used to identify specific inhibitors or broad-spectrum enzyme inhibitors. == Other applications ==